Skip to primary navigation
Skip to main content
Skip to footer

A New York based ALS research organization that's leading the fight for a cure.

Search this website

DONATE

About Us
For Scientists
Understanding ALS
Take Action
News

The New York Times Features Daniel L. Doctoroff, Target ALS Founder

Changemakers | In the News | News

With A.L.S. in Family, Chief at Bloomberg Joins Fight

Read the full New York Times story.

Footer

Donate
Contact
Financial Reports
Call For Proposals
Annual Meeting
Privacy Policy
Credits

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

Target ALS Foundation
244 Madison Avenue #1025
New York, NY 10016
(332) 333-4140

Steck Insights WordPress Consulting

Get our Summer Impact Report in your inbox – a special recap of our Annual Meeting and the progress we're making in ALS research.

Name(Required)

First Last

Email(Required)

Interests(Required)

Academic Researcher

Industry

Person with ALS

Caregiver

Loved one of person with ALS

Interested in the fight against ALS

Government

Updates on AGRI (ALS Global Research Initiative)

Mark the options that best describe your interest in ALS

The New York Times Features Daniel L. Doctoroff, Target ALS Founder

With A.L.S. in Family, Chief at Bloomberg Joins Fight

ALS Genetic Mutations Explained

The Ultimate Guide to Cognitive Impairment, Dementia, and ALS

Science on Target November 2024 Newsletter

Join Us

Get our Summer Impact Report in your inbox – a special recap of our Annual Meeting and the progress we're making in ALS research.

With A.L.S. in Family, Chief at Bloomberg Joins Fight

Read more Interesting and Inspiring Articles

Join Us

Footer

Follow Us